Theo Melas-Kyriazi Overview

  • Primary Position
  • Chairman of the...

  • Active Board Seats
  • 2

Theo Melas-Kyriazi General Information

Biography

Mr. Theo Melas-Kyriazi serves as Chief Financial Officer at Levitronix. Mr. Melas-Kyriazi also serves as an Advisor Partner at Flagship Pioneering, an innovation enterprise that conceives, creates, resources and grows first-in-category life sciences companies, which he joined in April 2019. Mr. Melas-Kyriazi has served as a board member of Evelo Biosciences, Inc. since 2017 and of Codiak Biosciences, Inc. since 2019. He also served as a director at Valeant Pharmaceuticals International, Inc from 2003 to 2016. From 1986 to 2004, Mr. Melas-Kyriazi served in a variety of management roles at Thermo Fisher Scientific. Mr. Melas-Kyriazi received his M.B.A. from Harvard Business School. We believe Mr. Melas-Kyriazi's extensive financial and business experience in life sciences companies qualifies him to serve on our board of directors. He served as Chairman of the Board of Directors, Member of Audit Committee & Compensation Committee at Kaleido BioSciences.

Contact Information

Primary Position
Chairman of the Board of Directors, Member of Audit Committee & Compensation Committee, Kaleido BioSciences
Education
Harvard Business School, MBA (Master of Business Administration)
Harvard University, BA (Bachelor of Arts)
Gender
Male
Address
  • 65 Hayden Avenue
  • Lexington, MA 02421
  • United States

Theo Melas-Kyriazi Positions (2)

Firm name Firm type Title Location Industry Since
KSQ Company Chairman Lexington, MA Drug Discovery
Levitronix Investor Chief Financial Officer Waltham, MA Acquirer

Theo Melas-Kyriazi Board Seats (3)

Company Industry Ownership Status Financing Status Location Since
Kaleido BioSciences Drug Discovery Out of Business Formerly VC-backed Lexington, MA
KSQ Drug Discovery Privately Held (backing) Venture Capital-Backed Lexington, MA
Sonata Therapeutics Drug Discovery Privately Held (backing) Venture Capital-Backed Watertown, MA

Theo Melas-Kyriazi Network (115)

Board Members (115)

Name Company Representing Location From
Eric Lander Ph.D Codiak BioSciences Codiak BioSciences Cambridge, MA
Robert Langer Ph.D Moderna Self Cambridge, MA
Bausch Health Companies Self Laval, Canada
VERO Biotech AUA Private Equity Partners Atlanta, GA
KSQ Self Lexington, MA

Theo Melas-Kyriazi Advisory Roles (1)

Firm name Firm type Title Location Industry Since
Flagship Pioneering Investor Advisor Partner Cambridge, MA Venture Capital

Theo Melas-Kyriazi FAQs

  • Who is Theo Melas-Kyriazi?

    Mr. Theo Melas-Kyriazi serves as Chief Financial Officer at Levitronix.

  • How much does Theo Melas-Kyriazi typically invest?

    Theo Melas-Kyriazi's median deal size is .

  • What is Theo Melas-Kyriazi’s main position?

    Theo Melas-Kyriazi’s primary position is Chairman of the Board of Directors, Member of Audit Committee & Compensation Committee.

  • How many active board seats does Theo Melas-Kyriazi hold?

    Theo Melas-Kyriazi holds 3 board seats including Kaleido BioSciences, KSQ, and Sonata Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »